Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Int J Colorectal Dis. 2009 Feb 11;24(6):647–654. doi: 10.1007/s00384-009-0656-8

Table 1.

Selected characteristics of cases and controls, Markers of Adenomatous Polyps (MAP) Study

Variable Cases (n=162) Controls (n=211) P valuea
Demographic and major risk factors
 Age (years) 58.5 (8.6) 56.0 (9.9) 0.02
 Male (%) 58.6 34.6 <0.0001
 White race (%) 87.7 90.0 0.48
 College education (%) 18.5 24.2 0.31
 Family history of colorectal cancer (%) 19.9 36.5 0.0005
 Currently smoke cigarettes (%) 30.3 19.0 0.01
 Currently drink alcohol (%) 54.4 43.1 0.02
 Aspirin or NSAID use (%)b 47.5 54.0 0.21
 Total physical activity (METs/day)c 50.0 (15.7) 51.3 (13.8) 0.25
Dietary intakes
 Total energy (kcal/day) 2,023 (760) 1,968 (720) 0.88
 Total fat (g/day) 70.7 (33.5) 65.5 (29.8) 0.49
 Total polyunsaturated fat (g/day) 13.7 (5.9) 13.0 (6.6) 0.77
 Total linoleic acids (g/day) 11.9 (5.3) 11.2 (6.0) 0.26
 Total red meat (servings/week) 4.6 (4.4) 4.0 (3.3) 0.16
 Total fruits and vegetables (servings/day) 6.4 (3.5) 6.4 (3.8) 0.95
Body measurement
 Body mass index (kg/m2)
± SD 26.4 (5.9) 26.6 (5.3) 0.98
 <25 (%) 35.8 38.9 0.83
 25 to <30 37.7 36.0
 ≥30 26.5 25.1

Continuous variables presented as mean (SD) and categorical variables as proportions (percent)

a

For categorical variables, based on χ2 test, and for continuous variables, based on analysis of covariance (ANCOVA) for age- and sex-adjusted mean differences (exception: age variable adjusted only for sex)

b

Nonsteroidal anti-inflammatory drug

c

Metabolic equivalents=the equivalent of a person’s energy expenditure at rest